John Bischof Assumes Leadership Roles in OACA and CTSI

Effective Jan. 1, 2022, John Bischof, PhD, will assume a leadership role in the Office of Academic Clinical Affairs and provide oversight of these interdisciplinary grant programs:

• Minnesota Partnership for Biotechnology and Medical Genomics - This program funds four to six joint projects with Mayo Clinic each year in human health related research and encourages novel applications of recent advances in biotechnology, genomics, proteomics, imaging and bioinformatics with a project completion goal of two years and expectation of successful NIH application to follow. The awarded joint projects ideally lead to development of a commercializable product or clinical trial.

• Minnesota Regenerative Medicine Program -This state funded initiative supports grants for research, clinical trials, and bio-business development that promote, advance, improve, or enhance awareness of regenerative medicine.

• Faculty Research Development Grants - This program supports new or expanding interdisciplinary research that addresses significant and/or innovative issues with a high potential for return on investment. Clinical research is broadly defined to include pre-clinical bench, development of new tools and approaches to clinical practice, responding to community health concerns and societal factors directly influencing public health and well-being.

Additionally, he will assume leadership for the Clinical Translational Science Institute’s Office of Discovery and Translation, and its funding programs:

• Committee for Pharmaceutical Development which focuses on the development and commercialization of pharmaceutical products
• Translational Product Development Fund which advances non-pharma projects that have the potential to be commercialized
• Pediatric Health Innovation Programs which drives development of pediatric health innovations
• Translational Grant Program which supports other human health innovations in target priority areas